Evidence map›Paper›PMID 34681685›Full record

ReviewInternational journal of molecular sciences2021

IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives.

Michal Španko, Karolína Strnadová, Aleš Jan Pavlíček, Pavol Szabo, Ondřej Kodet, Jaroslav Valach, Barbora Dvořánková, Karel Smetana, Lukáš Lacina

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancers.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  12. Exploring the molecular mechanism of Xiao Ji (Asian biomedicine : research, reviews and news · 2025
    Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michal ŠpankoInstitute of Anatomy, First Faculty of Medicine, Charles University, 12800 Prague, Czech Republic.ORCID 0000-0003-0222-9944
Karolína StrnadováInstitute of Anatomy, First Faculty of Medicine, Charles University, 12800 Prague, Czech Republic.ORCID 0000-0002-2879-7029
Aleš Jan PavlíčekInstitute of Anatomy, First Faculty of Medicine, Charles University, 12800 Prague, Czech Republic.
Pavol SzaboInstitute of Anatomy, First Faculty of Medicine, Charles University, 12800 Prague, Czech Republic.ORCID 0000-0002-1944-1493
Ondřej KodetInstitute of Anatomy, First Faculty of Medicine, Charles University, 12800 Prague, Czech Republic.ORCID 0000-0002-1382-2535
Jaroslav ValachDepartment of Stomatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12801 Prague, Czech Republic.
Barbora DvořánkováInstitute of Anatomy, First Faculty of Medicine, Charles University, 12800 Prague, Czech Republic.
Karel SmetanaInstitute of Anatomy, First Faculty of Medicine, Charles University, 12800 Prague, Czech Republic.ORCID 0000-0002-7878-8403
Lukáš LacinaInstitute of Anatomy, First Faculty of Medicine, Charles University, 12800 Prague, Czech Republic.ORCID 0000-0002-1750-9933

Funding

Charles University in Prague PROGRES Q28European Structural and Investment Funds; Operational Program Research, Development and Education CZ.02.1.01/0.0/0.0/16_019/0000785
6 · The paper itself

Abstract

Interleukin-6 (IL-6) is a highly potent cytokine involved in multiple biological processes. It was previously reported to play a distinct role in inflammation, autoimmune and psychiatric disorders, ageing and various types of cancer. Furthermore, it is understood that IL-6 and its signaling pathways are substantial players in orchestrating the cancer microenvironment. Thus, they appear to be potential targets in anti-tumor therapy. The aim of this article is to elucidate the role of IL-6 in the tumor ecosystem and to review the possible therapeutic approaches in head and neck cancer.

Indexed as

Tumor MicroenvironmentHead and Neck NeoplasmsHumansInflammationInterleukin-6Signal TransductionInterleukin-6cancer microenvironmenthead and neck cancerIL-6targeted therapy

Identifiers

PMID34681685
PMCPMC8540903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.